InvestorsHub Logo
Followers 79
Posts 24490
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Tuesday, 04/16/2024 8:36:51 AM

Tuesday, April 16, 2024 8:36:51 AM

Post# of 27395
JAGX - .1188 Pre-market at .146/.1484

Jaguar Health Licenses FDA-Approved Oral Mucositis Product For U.S. Market, Initiating Commercial Footprint In Its Core Focus Area Of Cancer Supportive Care; Planning To Begin Commercial Launch In Q3 2024 For Gelclair

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.